Dibenz[b,e]oxepin derivative and pharmaceutical compositions the

Details Dibenz[b,e]oxepin derivative and pharmaceutical compositions the Dibenz[b,e]oxepin derivative and pharmaceutical compositions the

1987-03-02

1992-05-26

Raymond, Richard L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

548215, 548525, 549354, 514212, 5142282, 5142328, 514253, 514320, 514374, 514422, 540596, 540600, 544 62, 544137, 544147, 544369, 544375, 544 587, 546196, A61K 31335, C07D31312

Patent

active

051168634

ABSTRACT:
Novel dibenz[b,e]oxepin derivatives are employed in the treatment and control of allergic conditions such as allergic asthma and also employed in the treatment of inflammation.

REFERENCES:
patent: 3354155 (1967-11-01), Tretter
patent: 3420851 (1969-01-01), Bloom et al.
patent: 3509176 (1970-04-01), Winter et al.
patent: 4282365 (1981-08-01), Rokach
patent: 4396550 (1983-08-01), Takizawa
patent: 4465835 (1984-08-01), Takizawa
patent: 4585788 (1986-04-01), Helsley et al.
patent: 4596804 (1986-06-01), Takizawa
patent: 4871865 (1989-10-01), Lever et al.
patent: 4923892 (1990-05-01), Lever et al.
Wellcome Foundation Ltd., Chemical Abstracts, vol. 107 (1987) 58,673r.
Metvosova, Arz.-Forsch., vol. 13 (1963) 1039:43.
Benesova, Arz.-Forsch., vol. 14 (1964) 100:3.
Chem. Abs., vol. 63 (1965) 16366a.
Drugs, vol. 13 (1977) 161:218.
J. Med. Chem., vol. 19, No. 7 (1976) 941:6.
J. Med. Chem., vol. 20, No. 11 (1977) 1499:501.
J. Med. Chem., vol. 21, No. 7 (1978) 633:9.

Affiliated with

Also associated with

Rating

Dibenz[b,e]oxepin derivative and pharmaceutical compositions the does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dibenz[b,e]oxepin derivative and pharmaceutical compositions the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dibenz[b,e]oxepin derivative and pharmaceutical compositions the will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-420211